Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Watchful Waiting × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Uterine Cervical Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Neuroblastoma 1 Muscle-invasive Bladder Cancer 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Body Weight Changes 1 Anorexia 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Temozolomide 55 Bevacizumab 51 Radiotherapy 34 Radiosurgery 24 Carboplatin 20 pembrolizumab 15 Irinotecan 14 Etoposide 14 Nivolumab 13 Cisplatin 13 Carmustine 13 Cyclophosphamide 12 Pemetrexed 11 Ipilimumab 11 Erlotinib Hydrochloride 11 Magnetic Resonance Spectroscopy 10 Surgical Procedures, Operative 9 Lapatinib 9 Capecitabine 9 Topotecan 8 Thalidomide 8 Aminolevulinic Acid 8 Lomustine 7 Gefitinib 7 Filgrastim 7 trametinib 6 osimertinib 6 encorafenib 6 binimetinib 6 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06974370 2025-05-15

ACTION-Brain

University of Vermont Medical Center

Phase 2 Not yet recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡